However, TM6SF2 knockdown significantly increased in lysoPC and lysoPE, both of which were recently identified as early biomarkers of NAFLD and are increased in NALFD patients with hepatitis [22]. The gene discussed is TM6SF2; the disease is hepatitis A virus infection.